Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Depreciation & Amortization (CF) (2022 - 2025)

Gossamer Bio's Depreciation & Amortization (CF) history spans 4 years, with the latest figure at $6000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 94.44% year-over-year to $6000.0; the TTM value through Dec 2025 reached $24000.0, down 97.23%, while the annual FY2025 figure was $24000.0, 97.12% down from the prior year.
  • Depreciation & Amortization (CF) reached $6000.0 in Q4 2025 per GOSS's latest filing, roughly flat from $6000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $500000.0 in Q2 2022 to a low of $6000.0 in Q1 2025.
  • Average Depreciation & Amortization (CF) over 4 years is $281875.0, with a median of $303500.0 recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): increased 10.62% in 2023, then tumbled 98.0% in 2025.
  • A 4-year view of Depreciation & Amortization (CF) shows it stood at $460000.0 in 2022, then crashed by 33.26% to $307000.0 in 2023, then crashed by 64.82% to $108000.0 in 2024, then tumbled by 94.44% to $6000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Depreciation & Amortization (CF) are $6000.0 (Q4 2025), $6000.0 (Q3 2025), and $6000.0 (Q2 2025).